TrialAnnals of hematology2010

Comparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial.

Cornelius F Waller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.